908 Devices (NASDAQ:MASS) Stock Crosses Below 50 Day Moving Average – What’s Next?

908 Devices Inc. (NASDAQ:MASS)’s stock price passed below its 50 day moving average during trading on Tuesday. The stock has a 50 day moving average of $11.19 and traded as low as $9.82. 908 Devices shares last traded at $9.98, with a volume of 898,536 shares traded.

908 Devices News Roundup

Here are the key news stories impacting 908 Devices this week:

• Positive Sentiment: Third-quarter revenue rose 35% year over year to a record $19 million, driven by the FTIR portfolio, and device shipments reached a company record. Revenue exceeded analyst estimates of $18.31 million. 908 Devices Q3 2026 results
• Positive Sentiment: The quarterly loss of $0.11 per share was narrower than the $0.15–$0.16 loss expected by analysts. 908 Devices Q3 earnings report
• Neutral Sentiment: 2026 revenue guidance is $68.5 million–$70.0 million, with the midpoint roughly in line with the $69.1 million analyst consensus—solid visibility, but not an obvious forecast beat. 908 Devices Q3 2026 results
• Negative Sentiment: The company remains loss-making, which may temper the upbeat revenue and shipment figures. The reported short-interest entry lists zero shares and zero days to cover despite describing a significant increase, so it appears inconsistent and offers little reliable signal. 908 Devices earnings information

Wall Street Analyst Weigh In

A number of research analysts have recently commented on MASS shares. Stifel Nicolaus upped their price objective on shares of 908 Devices from $10.00 to $12.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Canaccord Genuity Group initiated coverage on 908 Devices in a research report on Thursday, September 10th. They set a “buy” rating and a $13.50 target price on the stock. Wall Street Zen lowered 908 Devices from a “buy” rating to a “hold” rating in a research note on Saturday, September 12th. Weiss Ratings restated a “sell (d-)” rating on shares of 908 Devices in a research note on Wednesday, November 4th. Finally, Roth Capital upped their price target on 908 Devices from $11.00 to $13.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Three research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $12.83.

908 Devices Price Performance

The firm has a market capitalization of $412.47 million, a price-to-earnings ratio of -10.51 and a beta of 0.66. The business has a 50 day moving average of $11.19 and a 200 day moving average of $8.51.

908 Devices (NASDAQ:MASS) last posted its quarterly earnings results on Tuesday, November 10th. The company reported ($0.11) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.04. The firm had revenue of $18.95 million for the quarter, compared to the consensus estimate of $18.31 million. 908 Devices had a negative net margin of 56.96% and a negative return on equity of 12.54%. On average, sell-side analysts forecast that 908 Devices Inc. will post -0.59 EPS for the current fiscal year.

Insider Transactions at 908 Devices

In related news, Director Christopher Brown sold 30,000 shares of the company’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $10.95, for a total value of $328,500.00. Following the sale, the director owned 775,559 shares of the company’s stock, valued at $8,492,371.05. The trade was a 3.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Joseph H. Iv Griffith sold 11,459 shares of the company’s stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $10.95, for a total transaction of $125,476.05. Following the completion of the sale, the chief financial officer directly owned 121,497 shares in the company, valued at approximately $1,330,392.15. The trade was a 8.62% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 134,115 shares of company stock valued at $1,473,296. Company insiders own 28.20% of the company’s stock.

Institutional Investors Weigh In On 908 Devices

A number of institutional investors have recently added to or reduced their stakes in MASS. First Light Asset Management LLC boosted its holdings in 908 Devices by 3.5% during the second quarter. First Light Asset Management LLC now owns 6,282,804 shares of the company’s stock valued at $54,660,000 after purchasing an additional 210,241 shares in the last quarter. AWM Investment Company Inc. acquired a new position in shares of 908 Devices in the 2nd quarter worth approximately $42,454,000. BlackRock Inc. acquired a new position in shares of 908 Devices in the 2nd quarter worth approximately $16,915,000. Granahan Investment Management LLC lifted its position in shares of 908 Devices by 662.6% during the 1st quarter. Granahan Investment Management LLC now owns 695,070 shares of the company’s stock worth $4,254,000 after buying an additional 603,929 shares during the period. Finally, Meros Investment Management LP bought a new position in shares of 908 Devices during the 2nd quarter worth approximately $3,143,902. 88.06% of the stock is owned by institutional investors and hedge funds.

About 908 Devices

908 Devices Inc. is a Boston-based analytical technology company that develops purpose-built mass spectrometers for use outside traditional laboratory environments. Its instruments are designed to provide rapid chemical and biological analysis in the field, helping users identify unknown substances and make time-sensitive decisions. The company’s product portfolio includes the MX908 handheld mass spectrometer, which is used to detect and identify chemical threats, explosives, narcotics and other hazardous materials.